Pounds J G, Long G J, Rosen J F
Institute of Chemical Toxicology, Wayne State University, Detroit, MI 48201.
Environ Health Perspect. 1991 Feb;91:17-32. doi: 10.1289/ehp.919117.
To fully understand the significance of bone as a target tissue of lead toxicity, as well as a reservoir of systemic lead, it is necessary to define the effects of lead on the cellular components of bone. Skeletal development and the regulation of skeletal mass are ultimately determined by the four different types of cells: osteoblasts, lining cells, osteoclasts, and osteocytes. These cells, which line and penetrate the mineralized matrix, are responsible for matrix formation, mineralization, and bone resorption, under the control of both systemic and local factors. Systemic components of regulation include parathyroid hormone, 1,25-dihydroxyvitamin D3, and calcitonin: local regulators include numerous cytokines and growth factors. Lead intoxication directly and indirectly alters many aspects of bone cell function. First, lead may indirectly alter bone cell function through changes in the circulating levels of those hormones, particularly 1,25-dihydroxyvitamin D3, which modulate bone cell function. These hormonal changes have been well established in clinical studies, although the functional significance remains to be established. Second, lead may directly alter bone cell function by perturbing the ability of bone cells to respond to hormonal regulation. For example, the 1,25-dihydroxyvitamin D3-stimulated synthesis of osteocalcin, a calcium-binding protein synthesized by osteoblastic bone cells, is inhibited by low levels of lead. Impaired osteocalcin production may inhibit new bone formation, as well as the functional coupling of osteoblasts and osteoclasts. Third, lead may impair the ability of cells to synthesize or secrete other components of the bone matrix, such as collagen or bone sialoproteins (osteopontin). Finally, lead may directly effect or substitute for calcium in the active sites of the calcium messenger system, resulting in loss of physiological regulation. The effects of lead on the recruitment and differentiation of bone cells remains to be established. Compartmental analysis indicates that the kinetic distribution and behavior of intracellular lead in osteoblasts and osteoclasts is similar to several other cell types. Many of the toxic effects of lead on bone cell function may be produced by perturbation of the calcium and cAMP messenger systems in these cells.
为了充分理解骨骼作为铅毒性的靶组织以及全身铅储存库的重要性,有必要明确铅对骨细胞成分的影响。骨骼发育和骨量调节最终由四种不同类型的细胞决定:成骨细胞、衬里细胞、破骨细胞和成骨细胞。这些细胞排列并穿透矿化基质,在全身和局部因素的控制下,负责基质形成、矿化和骨吸收。调节的全身成分包括甲状旁腺激素、1,25 - 二羟基维生素D3和降钙素;局部调节因子包括多种细胞因子和生长因子。铅中毒直接和间接改变骨细胞功能的许多方面。首先,铅可能通过改变那些调节骨细胞功能的激素的循环水平,特别是1,25 - 二羟基维生素D3,间接改变骨细胞功能。这些激素变化在临床研究中已得到充分证实,尽管其功能意义仍有待确定。其次,铅可能通过干扰骨细胞对激素调节的反应能力直接改变骨细胞功能。例如,低水平的铅会抑制1,25 - 二羟基维生素D3刺激的骨钙素合成,骨钙素是成骨细胞合成的一种钙结合蛋白。骨钙素产生受损可能会抑制新骨形成以及成骨细胞和破骨细胞的功能耦合。第三,铅可能损害细胞合成或分泌骨基质其他成分的能力,如胶原蛋白或骨唾液蛋白(骨桥蛋白)。最后,铅可能直接影响钙信使系统的活性位点或替代钙,导致生理调节丧失。铅对骨细胞募集和分化的影响仍有待确定。区室分析表明,成骨细胞和破骨细胞内铅的动力学分布和行为与其他几种细胞类型相似。铅对骨细胞功能的许多毒性作用可能是由这些细胞中钙和cAMP信使系统的扰动产生的。